Tenaya Therapeutics, Inc. (TNYA)
0.389
0.00 (0.00%)
USD |
NASDAQ |
Oct 23, 16:00
0.3897
0.00 (0.00%)
After-Hours: 20:00
Tenaya Therapeutics Market Cap : 87.23M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 87.23M |
| October 22, 2026 | 87.00M |
| October 21, 2026 | 87.49M |
| October 20, 2026 | 91.93M |
| October 19, 2026 | 84.67M |
| October 16, 2026 | 85.36M |
| October 15, 2026 | 91.58M |
| October 14, 2026 | 87.56M |
| October 13, 2026 | 116.82M |
| October 12, 2026 | 126.80M |
| October 09, 2026 | 130.12M |
| October 08, 2026 | 122.03M |
| October 07, 2026 | 119.60M |
| October 06, 2026 | 122.54M |
| October 05, 2026 | 126.49M |
| October 02, 2026 | 126.49M |
| October 01, 2026 | 126.85M |
| September 30, 2026 | 135.35M |
| September 29, 2026 | 132.99M |
| September 28, 2026 | 132.25M |
| September 25, 2026 | 136.69M |
| September 24, 2026 | 139.02M |
| September 23, 2026 | 148.28M |
| September 22, 2026 | 152.97M |
| September 21, 2026 | 151.09M |
| Date | Value |
|---|---|
| September 18, 2026 | 152.32M |
| September 17, 2026 | 150.73M |
| September 16, 2026 | 147.48M |
| September 15, 2026 | 150.35M |
| September 14, 2026 | 155.37M |
| September 11, 2026 | 143.51M |
| September 10, 2026 | 145.48M |
| September 09, 2026 | 148.22M |
| September 08, 2026 | 148.75M |
| September 04, 2026 | 153.19M |
| September 03, 2026 | 155.91M |
| September 02, 2026 | 156.80M |
| September 01, 2026 | 153.69M |
| August 31, 2026 | 154.23M |
| August 28, 2026 | 154.74M |
| August 27, 2026 | 155.88M |
| August 26, 2026 | 156.11M |
| August 25, 2026 | 157.27M |
| August 24, 2026 | 151.29M |
| August 21, 2026 | 156.36M |
| August 20, 2026 | 154.83M |
| August 19, 2026 | 159.85M |
| August 18, 2026 | 156.62M |
| August 17, 2026 | 156.98M |
| August 14, 2026 | 163.26M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.189B |
| Oncolytics Biotech, Inc. | 62.61M |
| Sangamo Therapeutics, Inc. | 47.64M |
| Sarepta Therapeutics, Inc. | 1.873B |
| Anixa Biosciences, Inc. | 103.41M |
Market Cap Related Metrics
| PS Ratio | 56.30 |
| Price to Book Value | 1.257 |
| Price | 0.389 |
| Earnings Yield | -135.6% |